Spectral AI, Inc. MDAIW
Nov 4, 2026, 3:46 PM EST
- YTD
- -8.00%
- 1 year
- -8.00%
- Market cap
- 16.09M
- Revenue (ttm)
- 27.26M
- Profit margin
- -40.78%
- YTD return
- -8.00%
- 1-year return
- -8.00%
- Volume
- 8.28K
- Open
- 0.8325
- Previous close
- 0.4999
- Day's range
- 0.455 – 0.4625
- 52-week range
- 0.455 – 0.4625
1D -0.0399 (-7.98%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 137.60%
- Free cash flow
- -7.45M
- Total cash
- 3.70M
- Total debt
- 8.06M
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Consensus EPS estimate 0.00.
About Spectral AI, Inc.
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- spectral-ai.com
News
Spectral AI's DeepView™ System Showcased at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly 
Spectral AI Submits New Technology Add-On Payment (NTAP) Application for DeepView™ System 
Spectral AI Announces Upcoming Presentation at ACS Clinical Congress 2026 Highlighting the Use of Artificial Intelligence and Multi-Spectral Imaging in the Assessment of Burn Wounds 
Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference 
Spectral AI Schedules 2026 Second Quarter Financial Results and Conference Call 
Spectral AI Names Darcy Bajko Chief Commercial Officer to Lead Global Sales Launch of FDA-Cleared DeepView® System for Burn Indication 
Spectral AI to Participate in 2026 British Burn Association Annual Conference 
Spectral AI, Inc. (MDAI) Q1 2026 Earnings Call Transcript 
Spectral AI (NASDAQ:MDAIW) Shares Down 8.6% – Should You Sell?
Your note
Sign in to keep a note on MDAIW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Clear Street Derivatives LLC | 9.01% | 759,548 | 347.95K | Sep 29, 2024 |
| Cowen and Company, LLC | 4.27% | 360,384 | 165.09K | Sep 29, 2024 |
| Q Global Advisors, LLC | 2.51% | 211,791 | 97.02K | Sep 29, 2024 |
| Balyasny Asset Management LLC | 2.26% | 190,324 | 87.19K | Sep 29, 2024 |
| Aristeia Capital, LLC | 1.67% | 140,656 | 64.43K | Sep 29, 2024 |
| Goldman Sachs Group Inc | 1.47% | 123,629 | 56.63K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Franklin K2 Alternative Strategies Fd | 0.24% | 19,875 | 9.10K | Nov 29, 2023 |